Regulation Mechanism for the Binding between the SARS-CoV-2 Spike Protein and Host Angiotensin-Converting Enzyme II

被引:12
|
作者
Chen, Haiyi [1 ,2 ]
Kang, Yu [2 ]
Duan, Mojie [1 ]
Hou, Tingjun [2 ,3 ]
机构
[1] Chinese Acad Sci, Innovat Acad Precis Measurement Sci & Technol, Natl Ctr Magnet Resonance Wuhan, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan 430071, Hubei, Peoples R China
[2] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou Inst Innovat Med, Hangzhou 310058, Zhejiang, Peoples R China
[3] Zhejiang Univ, State Key Lab CAD & CG, Hangzhou 310058, Zhejiang, Peoples R China
来源
JOURNAL OF PHYSICAL CHEMISTRY LETTERS | 2021年 / 12卷 / 27期
基金
中国国家自然科学基金;
关键词
HEPARAN-SULFATE PROTEOGLYCANS; ENTRY;
D O I
10.1021/acs.jpclett.1c01548
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is mainly mediated through the interaction between the spike protein (S-pro) of the virus and the host angiotensin-converting enzyme II (ACE2). The attachment of heparan sulfate (HS) to S-pro is necessary for its binding to ACE2. In this study, the binding process of the receptor-binding domain (RBD) of S-pro to ACE2 was explored by enhanced sampling simulations. The free-energy landscape was characterized to elucidate the binding mechanism of S-pro to ACE2 with and without HS fragment DP4. We found that the stability of the T470-F490 loop and the hydrophobic interactions contributed from F486/Y489 in the T470-F490 loop of S-pro are quite crucial for the binding, which is enhanced by the presence of DP4. Our study provides valuable insights for rational drug design to prevent the invasion of SARS-CoV-2.
引用
收藏
页码:6252 / 6261
页数:10
相关论文
共 50 条
  • [21] Computational insights into differential interaction of mammalian angiotensin-converting enzyme 2 with the SARS-CoV-2 spike receptor binding domain
    Lupala, Cecylia Severin
    Kumar, Vikash
    Su, Xiao-dong
    Wu, Chun
    Liu, Haiguang
    [J]. Computers in Biology and Medicine, 2022, 141
  • [22] Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
    Xiangyu Chen
    Ren Li
    Zhiwei Pan
    Chunfang Qian
    Yang Yang
    Renrong You
    Jing Zhao
    Pinghuang Liu
    Leiqiong Gao
    Zhirong Li
    Qizhao Huang
    Lifan Xu
    Jianfang Tang
    Qin Tian
    Wei Yao
    Li Hu
    Xiaofeng Yan
    Xinyuan Zhou
    Yuzhang Wu
    Kai Deng
    Zheng Zhang
    Zhaohui Qian
    Yaokai Chen
    Lilin Ye
    [J]. Cellular & Molecular Immunology, 2020, 17 : 647 - 649
  • [23] Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor
    Chen, Xiangyu
    Li, Ren
    Pan, Zhiwei
    Qian, Chunfang
    Yang, Yang
    You, Renrong
    Zhao, Jing
    Liu, Pinghuang
    Gao, Leiqiong
    Li, Zhirong
    Huang, Qizhao
    Xu, Lifan
    Tang, Jianfang
    Tian, Qin
    Yao, Wei
    Hu, Li
    Yan, Xiaofeng
    Zhou, Xinyuan
    Wu, Yuzhang
    Deng, Kai
    Zhang, Zheng
    Qian, Zhaohui
    Chen, Yaokai
    Ye, Lilin
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2020, 17 (06) : 647 - 649
  • [24] Regulation of the Expression of SARS-CoV-2 Receptor Angiotensin-Converting Enzyme 2 in Nasal Mucosa
    Takabayashi, Tetsuji
    Yoshida, Kanako
    Imoto, Yoshimasa
    Schleimer, Robert P.
    Fujieda, Shigeharu
    [J]. AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2022, 36 (01) : 115 - 122
  • [25] Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2
    Zhu, Junjie
    Yan, Huimin
    Shi, Mengyao
    Zhang, Min
    Lu, Jia
    Wang, Jiabao
    Chen, Lu
    Wang, Yu
    Li, Lin
    Miao, Lin
    Zhang, Han
    [J]. PHYTOTHERAPY RESEARCH, 2023, 37 (08) : 3508 - 3521
  • [26] Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein
    Sadremomtaz, Afsaneh
    Al-Dahmani, Zayana M.
    Ruiz-Moreno, Angel J.
    Monti, Alessandra
    Wang, Chao
    Azad, Taha
    Bell, John C.
    Doti, Nunzianna
    Velasco-Velazquez, Marco A.
    de Jong, Debora
    de Jonge, Jorgen
    Smit, Jolanda
    Domling, Alexander
    van Goor, Harry
    Groves, Matthew R.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (04) : 2836 - 2847
  • [27] Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2
    Verkhivker, Gennady
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) : 1 - 31
  • [28] Inhibitory mechanism of Ambroxol and Bromhexine Hydrochlorides as potent blockers of molecular interaction between SARS-CoV-2 spike protein and human angiotensin-converting Enzyme-2
    Kehinde, Idowu A.
    Egbejimi, Anu
    Kaur, Manvir
    Onyenaka, Collins
    Adebusuyi, Tolulope
    Olaleye, Omonike A.
    [J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2022, 114
  • [29] Chiral distinction between hydroxychloroquine enantiomers in binding to angiotensin-converting enzyme 2, the forward receptor of SARS-CoV-2
    Aiello, Federica
    Balzano, Federica
    Barretta, Gloria Uccello
    D'Acquarica, Ilaria
    Mazzoccanti, Giulia
    Agranat, Israel
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 237
  • [30] Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection
    Alabsi, Sarah
    Dhole, Atharva
    Hozayen, Sameh
    Chapman, Scott A.
    [J]. MICROORGANISMS, 2023, 11 (03)